Abstract: External-signal influence on content item performance is determined. Content item performance data is received that reflects historic performance of a content item for multiple presentations of the content item. Signal data is received that corresponds to at least one signal that is temporally correlated with the content item performance data and that is external to each user, publisher and content provider involved in any of the presentations. Using the content item performance data and the signal data, an influence value for the signal with regard to the content item is determined. A content item prediction model is modified based on the influence value.

Abstract: Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Abstract: Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Abstract: The invention provides a silica-alumina-sodium oxide glass easy to melt and suitable for a low temperature ion exchange process. The glass is suitable for chemical tempering and consists of 55-60 wt % of SiO2, 0.1-2.5 wt % of B2O3, 11-16 wt % of Al2O3, 14-17 wt % of Na2O, 1-8 wt % of K2O, 0-8 wt % of ZrO2, 0-5 wt % of CaO, 0-5 wt % of MgO and 0-1 wt % of Sb2O3. By reasonably setting the composition, the difficulty in glass production decreases and the glass melting temperature is reduced obviously, which is favorable to reduce energy consumption and improve yield of products. Under the condition that tempering temperature is 380?-500? and tempering time is 4-12 h, the surface compressive stress can be 610-1100 Mpa, the depth of a stress layer can be 31-80 ?m, and the glass is reinforced and has high shock resistance. The glass of the invention has high wear resistance and can be used as a protective glass material of high-grade electronic display products such as mobile phones and PDAs.

Abstract: Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Abstract: The present invention provides a method and a system for cleaning furnace, including the steps of introducing a nitrogen gas flow into a cleaning agent tank to carry the cleaning agent, introducing the nitrogen gas carrying the cleaning agent into the furnace via a pipeline to clean the furnace; and generating a steam by mixing and igniting a hydrogen gas flow and an oxygen gas flow, and then introducing the steam into the furnace to clean the furnace. The method for cleaning furnace according to the invention can effectively remove metal and non-metal impurities deposits in a furnace of semiconductor oxidation furnace equipment.

Abstract: Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.

Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, dyslipidemia.

Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.

Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.

Abstract: Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Abstract: The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.

Abstract: Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Abstract: Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Abstract: Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.

Abstract: Combination therapy comprising PPAR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.